Literature DB >> 13439023

Studies on the destruction of red blood cells. XII. Factors influencing the role of S hemoglobin in the pathologic physiology of sickle cell anemia and related disorders.

M S GREENBERG, E H KASS, W B CASTLE.   

Abstract

Entities:  

Keywords:  ANEMIA, SICKLE CELL

Mesh：

Substances：

Year:  1957        PMID： 13439023      PMCID： PMC441759          DOI： 10.1172/JCI103489

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  Studies on abnormal hemoglobins. XI. Sickle cell-thalassemia disease in the Negro; the significance of the S+A+F and S+A patterns obtained by hemoglobin analysis.

Authors:  K SINGER; L SINGER; S R GOLDBERG
Journal:  Blood       Date:  1955-05       Impact factor: 22.113

2.  The biophysics of the variants of sickle-cell disease.

Authors:  R C GRIGGS; J W HARRIS
Journal:  AMA Arch Intern Med       Date:  1956-03

3.  Studies on the destruction of red blood cells. X. The biophysics and biology of sickle-cell disease.

Authors:  J W HARRIS; H H BREWSTER; T H HAM; W B CASTLE
Journal:  AMA Arch Intern Med       Date:  1956-02

4.  Splenomegaly in sickle cell anemia.

Authors:  R J WATSON; H C LICHTMAN; H D SHAPIRO
Journal:  Am J Med       Date:  1956-02       Impact factor: 4.965

5.  Clinical features of the genetic variants of sickle cell disease.

Authors:  E W SMITH; C L CONLEY
Journal:  Bull Johns Hopkins Hosp       Date:  1954-06

6.  Aseptic necrosis of bone in Caucasians with chronic hemolytic anaemia due to combined sickling and thalassemia traits.

Authors:  R S REICH; N J ROSENBERG
Journal:  J Bone Joint Surg Am       Date:  1953-10       Impact factor: 5.284

7.  Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance.

Authors:  K SINGER; L SINGER
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

8.  EXPERIMENTAL AND CLINICAL OBSERVATIONS ON INCREASED MECHANICAL FRAGILITY OF ERYTHROCYTES.

Authors:  S C Shen; W B Castle; E M Fleming
Journal:  Science       Date:  1944-10-27       Impact factor: 47.728

9.  Studies on the destruction of red blood cells. VIII. Molecular orientation in sickle cell hemoglobin solutions.

Authors:  J W HARRIS
Journal:  Proc Soc Exp Biol Med       Date:  1950-10

10.  Ratio of sickle-cell anemia hemoglobin to normal hemoglobin in sicklemics.

Authors:  I C WELLS; H A ITANO
Journal:  J Biol Chem       Date:  1951-01       Impact factor: 5.157
View more
  9 in total

1.  Studies of sickle cell disease. II. Hematuria in a case of sickle cell disease.

Authors:  A B HENDERSON; H O GRAY
Journal:  J Natl Med Assoc       Date:  1959-03       Impact factor: 1.798

2.  A critical review of human haemoglobin variants. II. Individual haemoglobins.

Authors:  G H BEAVEN; W B GRATZER
Journal:  J Clin Pathol       Date:  1959-03       Impact factor: 3.411

3.  The effect of methemoglobin formation in sickle cell disease.

Authors:  E BEUTLER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

Review 4.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

5.  Ligand kinetics of hemoglobin S containing erythrocytes.

Authors:  J P Harrington; D Elbaum; R M Bookchin; J B Wittenberg; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

6.  Clinical features of pulmonary lesions in sickle-cell anaemia.

Authors:  M C Petch; G R Serjeant
Journal:  Br Med J       Date:  1970-07-04

7.  Acid-base status of adults with sickle-cell anaemia.

Authors:  H H Kong; G A Alleyne
Journal:  Br Med J       Date:  1969-08-02

8.  On the nature of sickle-cell disease in the Arabian Peninsula.

Authors:  M A El-Hazmi
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

9.  Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes.

Authors:  A M Rudolph; S Yuan
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.